CoChat

Statin and Aspirin Use and the Risk of Mood Disorders among Men

Open access
Williams, Lana J., Pasco, Julie A., Mohebbi, Mohammadreza, Jacka, Felice N., Stuart, Amanda L., Venugopal, Kamalesh, O’Neil, Adrienne, Berk, Michael · 2016 · International Journal of Neuropsychopharmacology

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

BACKGROUND: There is a growing understanding that depression is associated with systemic inflammation. Statins and aspirin have anti-inflammatory properties. Given these agents have been shown to reduce the risk of a number of diseases characterized by inflammation, we aimed to determine whether a similar relationship exists for mood disorders (MD). METHODS: This study examined data collected from 961 men (24-98 years) participating in the Geelong Osteoporosis Study. MD were identified using a semistructured clinical interview (SCID-I/NP). Anthropometry was measured and information on medication use and lifestyle factors was obtained via questionnaire. Two study designs were utilized: a nested case-control and a retrospective cohort study. RESULTS: In the nested case-control study, exposure to statin and aspirin was documented for 9 of 142 (6.3%) cases and 234 of 795 (29.4%) controls (P < .001); after adjustment for age, exposure to these anti-inflammatory agents was associated with reduced likelihood of MD (OR 0.2, 95%CI 0.1-0.5). No effect modifiers or other confounders were identified. In the retrospective cohort study of 836 men, among the 210 exposed to statins or aspirin, 6 (2.9%) developed de novo MD during 1000 person-years of observation, whereas among 626 nonexposed, 34 (5.4%) developed de novo MD during 3071 person-years of observation. The hazard ratio for de novo MD associated with exposure to anti-inflammatory agents was 0.55 (95%CI 0.23-1.32). CONCLUSIONS: This study provides both cross-sectional and longitudinal evidence consistent with the hypothesis that statin and aspirin use is associated with a reduced risk of MD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ijnp/pyw008

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Survival plot (Kaplan-Meier) showing the probability of remaining free of de novo mood disorder (MD) for men exposed and not exposed to the antiinflammatory agents statins and aspirin.
Figure 1. Survival plot (Kaplan-Meier) showing the probability of remaining free of de novo mood disorder (MD) for men exposed and not exposed to the antiinflammatory agents statins and aspirin.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 32

Metadata

Authors
Williams, L. J., Pasco, J. A., Mohebbi, M., Jacka, F. N., Stuart, A. L., Venugopal, K., O’Neil, A., & Berk, M.
Affiliations
Deakin University (AU)
Corresponding author
Williams, Lana J.
Venue
International Journal of Neuropsychopharmacology
Published
2016-02-02
Volume
19
Issue
6
Pages
pyw008
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2400601767
Cited by
32
References
10
Citations by year
2025: 1 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 8 · 2016: 2
FWCI
1.82
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
  • Figshare (submittedVersion, cc-by-nc)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Pfizer
  • Sanofi
  • Geelong Region Medical Research Foundation
  • Beyond Blue
  • Servier
  • H. Lundbeck A/S
  • National Institutes of Health
  • Medical Research Council
  • National Health and Medical Research Council (1021345, 1026265, 299831, 1052865, 1064272, 299831, 628582, 628582, 1059660)
  • Cilag
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
statins, aspirin, mood disorders, depression, anti-inflammatory agents, systemic inflammation, men, Geelong Osteoporosis Study, medication use, risk mitigation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statin and Aspirin Use and the Risk of Mood Disorders among Men. https://app.cochat.ai/papers/10.1093/ijnp/pyw008
The paper
Williams, L. J., Pasco, J. A., Mohebbi, M., Jacka, F. N., Stuart, A. L., Venugopal, K., O’Neil, A., & Berk, M. (2016). Statin and Aspirin Use and the Risk of Mood Disorders among Men. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyw008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.